IDO1 and fatty liver disease: Notably, kynurenine was shown to trigger obesity by binding to the aryl hydrocarbon receptor (AhR), and blocking IDO or AhR in mice significantly attenuated long-term high-fat diet-induced obesity and liver steatosis [50].